| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 9.119 | 20.036 | 32.711 | 38.998 | 42.114 | 52.244 | 59.196 | 51.551 | 54.952 |
| Total Income - EUR | 0 | 9.119 | 20.036 | 56.349 | 90.628 | 104.137 | 122.922 | 83.542 | 93.209 | 97.776 |
| Total Expenses - EUR | 2.110 | 8.838 | 53.845 | 54.226 | 81.660 | 64.963 | 91.923 | 82.908 | 109.057 | 93.636 |
| Gross Profit/Loss - EUR | -2.110 | 281 | -33.809 | 2.124 | 8.968 | 39.174 | 31.000 | 634 | -15.847 | 4.140 |
| Net Profit/Loss - EUR | -2.110 | 89 | -34.011 | 1.559 | 8.062 | 38.183 | 30.290 | 151 | -16.894 | 2.083 |
| Employees | 0 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 |
Check the financial reports for the company - Masal Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.392 | 1.010 | 10.950 | 7.621 | 4.492 | 1.738 | 0 | 979 | 668 | 14.247 |
| Current Assets | 3.917 | 37.441 | 28.407 | 40.215 | 33.793 | 41.773 | 48.027 | 50.960 | 38.246 | 37.828 |
| Inventories | 3.863 | 37.418 | 28.225 | 37.429 | 24.637 | 35.209 | 21.150 | 22.199 | 18.310 | 29.641 |
| Receivables | 0 | -10 | 11 | 230 | 213 | 368 | 4.354 | 1.751 | 2.433 | 3.088 |
| Cash | 54 | 34 | 172 | 2.556 | 8.943 | 6.195 | 22.523 | 27.010 | 17.504 | 5.099 |
| Shareholders Funds | -2.065 | -1.955 | -35.932 | -33.714 | -24.999 | 13.542 | 43.532 | 43.818 | 26.791 | 28.724 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.374 | 40.407 | 75.290 | 81.550 | 63.284 | 29.969 | 4.495 | 8.121 | 12.124 | 23.351 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Masal Med S.r.l.